Bayer says trading is tough

Bayer, Germany’s largest drug company, said its full-year profit outlook had become more challenging as difficult plastics and chemicals markets temper sales growth from new pharmaceuticals. Second-quarter adjusted earnings rose to €2.2bn (£1.9bn), broadly in line with analyst forecasts.